Improving Head and Neck Cancer Outcomes: Technology, Used Wisely

Comment

Jolie Ringash et al. Int J Radiat Oncol Biol Phys. 2016.

. 2016 Nov 1;96(3):489-92.

doi: 10.1016/j.ijrobp.2016.04.021.

No abstract available

Comment on

Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer.
Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD. Walker GV, et al. Radiother Oncol. 2014 Sep;112(3):321-5. doi: 10.1016/j.radonc.2014.08.028. Epub 2014 Sep 9. Radiother Oncol. 2014. PMID: 25216572 Free PMC article. Clinical Trial.
Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD. Boero IJ, et al. J Clin Oncol. 2016 Mar 1;34(7):684-90. doi: 10.1200/JCO.2015.63.9898. Epub 2016 Jan 4. J Clin Oncol. 2016. PMID: 26729432 Free PMC article.
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J; PET-NECK Trial Management Group. Mehanna H, et al. N Engl J Med. 2016 Apr 14;374(15):1444-54. doi: 10.1056/NEJMoa1514493. Epub 2016 Mar 23. N Engl J Med. 2016. PMID: 27007578 Clinical Trial.